News
Zacks Investment Research on MSN5h
Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New DealsBayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...
Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...
MONTCO Today on MSN12h
GSK Bets Big on ‘Game-Changing’ Liver Disease DrugGSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback